Lei Wang

Medicine · Health Sciences

1h-index4citations17works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mycobacterium research and diagnosis(16), Colorectal Cancer Screening and Detection(11), Gastrointestinal disorders and treatments(7), Colorectal and Anal Carcinomas(6), Diverticular Disease and Complications(3)

Publications17 total

Supplementary Table S4 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Table S2 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Figure S3 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Figure S2 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Figure S2 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Table S3 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Table S1 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Figure S1 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Table S3 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Table S4 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Table S2 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Data from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Table S1 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Figure S1 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Data from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Figure S3 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
Cancer Epidemiology Biomarkers & Prevention·2023· 4 citedOpen Access

Frequent Co-authors

Po‐Hong Liu(17), Rasmi G. Nair(17), Celette Sugg Skinner(17), Caitlin C. Murphy(17), Eric J. Kim(17), Cynthia Ortiz(17), Ellen Hu(17), Jacquelyn M. Lykken(17), Theodore R. Levin(17), Beverly B. Green(17), Erin E. Hahn(17), Noel Santini(17), Ethan A. Halm(17)